A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 11, 2000, Pages 1451-1457

  Marshall, J K ^a,b   Rainsford, K D ^a,b   James, C ^a,b   Hunt, R H ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DRUG EFFECT; HUMAN; INTESTINE INJURY; NORMAL HUMAN; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH MUCOSA;

ADULT; ALENDRONATE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RADIOIMMUNOASSAY; STOMACH ULCER;

EID: 0033694952     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00864.x     Document Type: Article

References (22)

1. Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines
2. United Kingdom experience with alendronate and esophageal reactions
3. Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for esophagitis
4. Incidence of gastrointestinal side effects due to alendronate is high in clinical practice
5. Esophagitis associated with the use of alendronate
6. Primary aminobisphosphonates: A new class of gastrotoxic drugs: A comparison of alendronate and aspirin
7. Alendronate gastric ulcers
8. Effects of treatment with bisphosphonates on gastrointestinal and esophageal mucosa in patients with osteoporosis: Pamidronate versus alendronate
9. Alendronate induces gastric injury and delays ulcer healing in rodents
10. Esophageal irritation due to alendronate sodium tablets: Possible mechanisms
11. N-bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation
12. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury: Effect of scoring method
13. The effect of indomethacin-induced gastric mucosal injury on 24-h intragastric acidity and plasma gastrin concentration in healthy volunteers
14. Protein measurement with the folin phenol reagent
15. Effects of alendronate on gastric and duodenal mucosa
16. Effect of bisphosphonates on the surface hydrophobicity and phosphatidylcholine concentration of gastric mucosa
17. Factors influencing gastroduodenal mucosal prostaglandin concentrations: Roles of smoking and aging
18. Upper gastrointestinal toxicity of alendronate
19. Upper gastrointestinal tract safety profile of alendronate: The Fracture Intervention Trial
20. The effects of amino- versus alkyl-bisphosphonates on the healing of aspirin-induced stomach erosions
21. Alendronate and naproxen are synergistic in producing gastric ulcers
22. Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women